Who is sponsoring NCT04040517?

NCT04040517 is sponsored by Assiut University.

What drugs are being tested in NCT04040517?

Interventions in NCT04040517: Evoked potential audiometer.

What condition does NCT04040517 study?

NCT04040517 studies Hearing Impaired Children.

Is NCT04040517 still recruiting?

NCT04040517 is currently status unknown. Last updated 31 July 2019.

Last reviewed 2019-07-31 · How we verify

NCT04040517

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Auditory Steady State Response vsAuditory Brainstem Response

Status unknown Last updated 31 July 2019

What this trial tests

trial testing Evoked potential audiometer in Hearing Impaired Children in 40 participants. Status unknown.

Timeline

1 December 2019

Primary endpoint
1 June 2020

1 January 2021

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	40
Start date	1 December 2019
Primary completion	1 June 2020
Estimated completion	1 January 2021

Drugs / interventions tested

Evoked potential audiometer

Conditions studied

Hearing Impaired Children — all drugs for Hearing Impaired Children →

Sponsor

Assiut University

Who can join

Adults 1 Day to 4, any sex, with Hearing Impaired Children. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

All children with hearing loss should have access to resources necessary to reach their maximum potential. The following principles provide the foundation for effective EHDI\[Early Hearing Detection \& Intervention\] systems and have been updated and expanded since the 2000 JCIH \[ joint Committee on Infant Hearing \] position statement .

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hearing Impaired Children

Currently open trials in the same condition.

NCT06406088 — EarGenie MVP Performance Evaluation · NA · recruiting
NCT06317493 — Hearing Impairment in Children: Pupillometry and Hearing Thresholds Assessment · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04040517 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 31 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04040517.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing